C. HENDRICKS, L. JANSSEN, R. DELCOMBEL, J. DUBAIL, C. DEROANNE, A. COLIGE Laboratory of Connective Tissues Biology, GIGA-Cancer, University of Liège, Tour.

Slides:



Advertisements
Similar presentations
Presentation overview
Advertisements

Supplementary Figure 1. AB Supplementary Figure 1. L1 and Alu retrotransposition assay. A. Schematic of L1 retrotransposition plasmid (L1). ORF1 and ORF2.
Can Expression of VACM-1 Enhance Effects of Thalidomide on Endothelial Cell Growth? Drake Harper Zeeland East High School John Pelton Maria Burnatowska-Hledin.
P73 Shatil Amin March 27 th Content I.Structure and Function II.Regulation III.Is it involved in human cancers?
Suppl. Figure 1 A B Suppl. Figure 1. Relative (A) miR-21 and (B) miR-224 expression levels in HCC tumors in different stages (I,II,III,IV) assessed by.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
Characterization of the anti-angiogenic properties of arresten,an α1β1 integrin- dependent collagen-derived tumor suppressor E xperimental Cell Research.
Identification of SIP1-modulated genes during the epithelial-to-mesenchymal transition and interactions with KLF factors in EMT control Benjamin Koopmansch.
Triplex forming oligonucleotides (TFO)
Human cytomegalovirus (HCMV) is a member of the herpesvirus family. About 70-90% of the population is infected with HCMV. In healthy.
Control VEGF 165 b bevacizumab PC3 cells Saline VEGF 165 b A. B. C.D SalineVEGF 165 b Bevacizumab Vessels/mm -2 ** * Supplementary.
Products > PC-3 Transfection Reagent (Prostate Cancer Cells) Altogen Biosystems offers the PC-3 Transfection Reagent among a host of 100+ cell line specific.
Volume 342, Issue 1, Pages (January 2014)
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Volume 133, Issue 1, Pages (July 2007)
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Cell Physiol Biochem 2016;38: DOI: /
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Corresponding author:
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Molecular Therapy - Oncolytics
Cell Physiol Biochem 2017;44:1867– DOI: /
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Volume 142, Issue 4, Pages e3 (April 2012)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
T3 increased J7-TRα1 cell migration and proliferation both in vitro and in vivo. T3 increased J7-TRα1 cell migration and proliferation both in vitro and.
Volume 122, Issue 3, Pages (March 2002)
Volume 133, Issue 1, Pages (July 2007)
Chandra M.V. Goparaju, PhD  Journal of Thoracic Oncology 
Novel nanotechnology approach to target cancer - Switch from Proto-Oncogene to Tumor Suppressor. Alexander Kazansky (Sasha)
Molecular Therapy - Nucleic Acids
Volume 8, Issue 6, Pages (December 2005)
Volume 11, Issue 2, Pages (February 2005)
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
Volume 132, Issue 4, Pages (April 2007)
Volume 115, Issue 2, Pages (August 1998)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 147, Issue 5, Pages (November 2014)
NRP2 represses IGF-IR expression and signaling.
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production  Naoko Kanda, Shinichi.
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Volume 152, Issue 1, Pages (January 2019)
Volume 19, Issue 4, Pages (April 2017)
Volume 25, Issue 3, Pages (March 2017)
The Polycomb Protein Pc2 Is a SUMO E3
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 122, Issue 3, Pages (March 2002)
Volume 21, Issue 12, Pages (December 2017)
Volume 147, Issue 5, Pages (November 2014)
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Anke Sparmann, Dafna Bar-Sagi  Cancer Cell 
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
Volume 6, Issue 1, Pages (January 1997)
Volume 10, Issue 4, Pages (April 2018)
Volume 134, Issue 1, Pages (July 2008)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Molecular Therapy - Oncolytics
AMs contribute to the progression of EGFR-mutant lung adenocarcinoma.
Volume 1, Issue 3, Pages (April 2002)
miR-100 suppresses bladder cancer cell growth in vitro and in vivo.
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
AXL overexpression decreases proliferation in vitro.
Presentation transcript:

C. HENDRICKS, L. JANSSEN, R. DELCOMBEL, J. DUBAIL, C. DEROANNE, A. COLIGE Laboratory of Connective Tissues Biology, GIGA-Cancer, University of Liège, Tour de Pathologie, B23/3, B-4000 Sart-Tilman, Belgium Study of a new splice variant of Neuropilin-1: antagonistic functions in the regulation of tumor progression? Introduction Neuropilin-1 (NRP1) is a transmembrane glycoprotein and a co-receptor for several soluble factors, including some variants of the Vascular Endothelial Growth Factor A (VEGF-A). Therefore it contributes to regulate angiogenesis but is also linked to cancer formation. Neuropilin can be considered as a proteoglycan as it can be modified by the addition of a glycosaminoglycan side chain on serine 612. Six splice variants of NRP1 have been described in the literature. An additional form was recently identified. As compared to the full size NRP1 (NRP1-FS), it lacks the 7 amino acids encoded by the last 21 bases of exon 11. This new variant was named NRP1-Δ7. Objectives and methodology As the 7 amino acids deletion in the NRP1-Δ7 occurs 2 amino acids downstream of Ser612, the glycosylation process could be affected and the function of the entire molecule could be modified. The aim of this study was to characterize the functional properties of this new splice variant, especially in models relevant to tumorigenesis and angiogenesis. To this purpose, PC3 prostate cancer cells were engineered to express NRP1-FS or –Δ7 only in the presence of doxycycline. Key findings  The NRP1-Δ7 transcript is expressed in many different cell lines and represents from 10 to 30% of the total amount of NRP1 mRNA. Recombinant NRP1-Δ7 is less glycosylated on serine 612, which can modify its biological functions.  While NRP1-FS overexpression stimulates PC3 migration, increased expression of NRP1-Δ7 inhibits it.  NRP1-FS enhances cell proliferation in vitro and tumor growth in an anchorage-independent model (soft agar). On the contrary, NRP1-Δ7 reduced these two processes, although the synthesis of endogenous NRP1-FS is not modified. This suggests a mechanism of competition between the two isoforms.  Doxycycline-responsive PC3 cells were also used to form tumors in nude mice. While NRP1-FS overexpression favors tumor growth, NRP1-Δ7 represses it, which is potentially related to a decrease in tumor angiogenesis. Contact : #5135 Acknowledgment: F. Olivier, for technical assistance Ser612 Fig. 3: Proliferation of PC3 transfected with either NRP1-FS or –Δ7 was evaluated by DNA quantification. 18 hours after seeding, doxycycline was added in the culture medium (day 0) and cells were harvested 1, 3 or 5 days later. NRP1-FS was shown to elicit cell proliferation while NRP1-Δ7- expressing cells proliferated at a lower. Fig. 1: Expression of NRP1 in different human cell lines was measured by RT-PCR. NRP1-Δ7 represents 10-30% of the total amount of the NRP1 transcripts (A). Western blotting analysis of cells transfected with an empty vector (T0) or vectors coding for NRP1-FS or -Δ7 revealed very high molecular weight products in NRP1-FS that were much less abundant in NRP1-Δ7. These products are characteristic of glycosaminoglycans side chains (B). B Fig. 2: Migration of PC3 engineered to express NRP1-FS or -Δ7 in presence of doxycycline was assessed by wound healing assay. Due to the small difference in size (7a.a.), NRP1-FS and –Δ7 cannot be separated by SDS-PAGE. The relative production of recombinant NRP1 can be estimated by comparing NRP1 expression in absence and presence of Doxycycline (A). As compared to controls and to NRP1-FS expressing cells, a decreased migration rate was observed with cells producing NRP1- Δ7 (B). Fig. 4: Growth of PC3 expressing either NRP1-FS or –Δ7 was evaluated in soft agar in presence of doxycycline (dox+). PC3 overexpressing NRP1- FS formed a higher number of colonies as compared to the control condition. On the contrary, the expression of NRP1-Δ7 was associated with a decreased tumor growth in vitro. NRP1-FS NRP1-Δ7 Ratio = 2.64 Ratio = 3.82 A NRP1-FS NRP1-Δ7 NRP1-FS A Fig. 5: PC3 conditionally expressing NRP1-FS or –Δ7 were injected in the flanks of nude mice that receive (dox+) or not (ctrl, dox-) doxycycline in drinking water. Tumor growth was evaluated by measuring tumor weight. (A) Expression of NRP1-FS elicited tumor growth, while NRP1-Δ7 seemed to reduce the proliferation in vivo. (B) Tumors were also analyzed for CD31 expression by immunohistochemistry. Tumors expressing NRP1-Δ7 were less vascularized. B B A NRP1-Δ7